These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 7807026)

  • 41. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity.
    Noppen C; Schaefer C; Zajac P; Schütz A; Kocher T; Kloth J; Heberer M; Colonna M; De Libero G; Spagnoli GC
    Eur J Immunol; 1998 Apr; 28(4):1134-42. PubMed ID: 9565352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes.
    Sensi M; Castelli C; Salvi S; Mazzocchi A; Mortarini R; Nicolini G; Anichini A; Parmiani G
    J Immunother (1991); 1992 Oct; 12(3):207-11. PubMed ID: 1332745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
    Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
    J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
    Weekes MP; Carmichael AJ; Wills MR; Mynard K; Sissons JG
    J Immunol; 1999 Jun; 162(12):7569-77. PubMed ID: 10358214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.
    Boitel B; Ermonval M; Panina-Bordignon P; Mariuzza RA; Lanzavecchia A; Acuto O
    J Exp Med; 1992 Mar; 175(3):765-77. PubMed ID: 1371303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
    Bowness P; Allen RL; McMichael AJ
    Eur J Immunol; 1994 Oct; 24(10):2357-63. PubMed ID: 7523137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
    Elovaara I; Utz U; Smith S; Jacobson S
    J Neuroimmunol; 1995 Dec; 63(1):47-53. PubMed ID: 8557824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
    Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
    Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the V delta 1 variable region in the functional T-cell receptor alpha chain of a WT31+ cytotoxic T lymphocyte clone which specifically recognizes HLA-A2 molecule.
    Castelli C; Mazzocchi A; Salvi S; Anichini A; Sensi M
    Scand J Immunol; 1992 Apr; 35(4):487-94. PubMed ID: 1313600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients.
    Maccalli C; Farina C; Sensi M; Parmiani G; Anichini A
    J Immunol; 1997 Jun; 158(12):5902-13. PubMed ID: 9190943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction.
    MacDonald HR; Casanova JL; Maryanski JL; Cerottini JC
    J Exp Med; 1993 May; 177(5):1487-92. PubMed ID: 8478619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones.
    Kolowos W; Schmitt M; Herrman M; Harrer E; Löw P; Kalden JR; Harrer T
    J Immunol; 1999 Jun; 162(12):7525-33. PubMed ID: 10358208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment.
    Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
    Eur J Immunol; 2003 Oct; 33(10):2910-6. PubMed ID: 14515275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.